What is Journey Medical Corporation's return on equity?

Journey Medical Corporation (DERM) reported return on equity of -36.6% in Q1 2026.

What is the long-term trend for Journey Medical Corporation's return on equity?

Over 3 years (2021 to 2025), Journey Medical Corporation's return on equity has grown at a -36.0% compound annual growth rate (CAGR), from -168.1% to -44%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Journey Medical Corporation DERM Return on equity

Return on equity at other companies

Cumberland PharmaceuticalsCPIX

-29.4%-86.3pp

Arcutis Biotherapeutics, Inc.ARQT

-28.2%-13.0pp

HRO

HarrowHROW

-50%+17.5pp

Catalyst PharmaceuticalCPRX

24.5%-4.6pp

Mirum Pharmaceuticals, Inc.MIRM

-335.8%-377pp

Pulse Biosciences, Inc.PLSE

-80.7%+3.1pp

Other financials

Income statement

See full

Revenue$16.0M+21.5%

Gross profit$9.7M+16.7%

Operating income-$1.5M+55.1%

Net income-$2.2M+45.2%

EPS (diluted)-$0.08+55.6%

Balance sheet

See full

Cash & equivalents$27.2M+29.2%

Total debt$25.5M+1.2%

Total equity$30.8M+43.1%

Total assets$91.5M+7.7%

Cash flow

See full

Operating cash flow$2.9M+203%

CapEx$3.8M—

Free cash flow-$6.0M—

Valuation

See full

Market cap$194.94M+20.9%

Enterprise value$193.19M+16.2%

P/S3×+0.2×

Profitability

See full

Gross margin65.4%-1.0pp

Operating margin-9.8%—

Net margin-14.8%—

FCF margin-43%—

Returns & leverage

See full

Debt / equity0.8×-0.3×

Current ratio1.7×+0.4×

Where this comes from

Calculated from Journey Medical Corporation’s reported figures.

net income/total stockholders equity=-36.6%

Based on trailing twelve months.

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Journey Medical Corporation's return on equity?: Journey Medical Corporation (DERM) reported return on equity of -36.6% in Q1 2026.
What is the long-term trend for Journey Medical Corporation's return on equity?: Over 3 years (2021 to 2025), Journey Medical Corporation's return on equity has grown at a -36.0% compound annual growth rate (CAGR), from -168.1% to -44%.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.